Valuation Sernova Biotherapeutics Inc
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Toronto S.E.
13/11/2026
|
5-day change | 1st Jan Change | ||
| 0.1100 CAD | +4.76% |
|
0.00% | -15.38% |
Company Valuation: Sernova Biotherapeutics Inc
Data adjusted to current consolidation scope
| Fiscal Period: October | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 326.4 | 234.5 | 243.9 | 81.33 | 59.26 | 41.54 | - | - |
| Change | - | -28.16% | 3.99% | -66.65% | -27.14% | -29.9% | - | - |
| Enterprise Value (EV) | 326.4 | 234.5 | 235.1 | 75.79 | 63.76 | 41.54 | 41.54 | 41.54 |
| Change | - | -28.16% | 0.27% | -67.77% | -15.87% | -34.85% | 0% | 0% |
| P/E | -41.7x | -8.89x | -5.85x | -2.5x | -3x | -4.4x | -3.67x | -2.2x |
| PBR | - | - | 18.4x | -6.28x | -1.96x | - | - | - |
| PEG | - | -0x | -0.1x | 0.1x | 0.1x | 0.1x | -0.2x | -0x |
| Capitalization / Revenue | - | - | - | - | - | - | 16.6x | 0.33x |
| EV / Revenue | - | - | - | - | - | - | 16.6x | 0.33x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -4.52x | -3.49x | -2.2x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.03 | -0.09 | -0.13 | -0.1 | -0.05 | -0.025 | -0.03 | -0.05 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | 2.5 | 127.8 |
| EBITDA | -6.669 | -24.31 | -40.06 | -31.12 | -14.68 | - | - | - |
| EBIT 1 | -6.937 | -24.75 | -40.5 | -31.66 | -15.02 | -9.2 | -11.9 | -18.9 |
| Net income 1 | -6.966 | -24.42 | -39 | -32.19 | -15.74 | -11.3 | -13.9 | -20.9 |
| Net Debt | - | - | -8.722 | -5.544 | 4.503 | - | - | - |
| Reference price 2 | 1.2500 | 0.8000 | 0.7600 | 0.2500 | 0.1500 | 0.1100 | 0.1100 | 0.1100 |
| Nbr of stocks (in thousands) | 261,133 | 293,125 | 320,857 | 325,325 | 395,037 | 377,643 | - | - |
| Announcement Date | 14/02/22 | 26/01/23 | 29/01/24 | 23/12/24 | 19/12/25 | - | - | - |
1CAD in Million2CAD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.4x | - | - | - | 29.15M | ||
| 35.9x | 4.23x | 15.9x | 2.39% | 188B | ||
| 22.27x | 3.77x | 13.5x | 2.76% | 126B | ||
| 26.7x | 4.76x | 16.31x | 1.16% | 118B | ||
| 32x | 3.08x | 12.43x | 2.23% | 92.48B | ||
| 19.04x | 0.23x | 14.13x | 0.66% | 68.51B | ||
| 44.44x | 3.9x | 13.29x | 1.92% | 59.39B | ||
| 46.74x | 11.74x | 32.93x | -.--% | 55.48B | ||
| 28.66x | 7.1x | 18x | 1.4% | 49.62B | ||
| 45.81x | 3.44x | 12.72x | 0.5% | 35.17B | ||
| Average | 29.72x | 4.69x | 16.58x | 1.45% | 79B | |
| Weighted average by Cap. | 31.84x | 4.40x | 16.01x | 1.75% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SVA Stock
- Valuation Sernova Biotherapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
















